How to Address Resistance Mechanisms Against RAS Therapies Observed in Colorectal Cancer

Time: 1:30 pm
day: Day One Track B PM


  • Understanding resistance mechanisms dynamics in CRC and their implications to develop more effective therapies
  • An overview of the consequences of resistance mechanisms in CRC patients to improve patient outcomes and QoL
  • Developing strategies to overcome acquired resistance to RAS inhibition in CRC beyond targeting the RAS pathway